Clinical Study of Weishu capsule ( ) in treating precancerous lesions of chronic atrophic gastritis) in treating precancerous lesions of chronic atrophic gastritis
Back to article page
|Updated:2021-08-27
|
Clinical Study of Weishu capsule ( ) in treating precancerous lesions of chronic atrophic gastritis) in treating precancerous lesions of chronic atrophic gastritis
Chinese Journal of Integrative MedicineVol. 5, Issue 3, Pages: 193-196(1999)
Affiliations:
1. Institute of Digestive Diseases, Jiangsu Provincial Hospital of Traditional Chinese Medicine,Nanjing
2. Department of Pathology, Jiangsu Provincial Hospital of TCM,Nanjing
Weimin, L., Zhaowei, S., Hong, S. et al. Clinical Study of Weishu capsule () in treating precancerous lesions of chronic atrophic gastritis) in treating precancerous lesions of chronic atrophic gastritis., CJIM 5, 193–196 (1999). https://doi.org/10.1007/BF02935170
Lu Weimin, Shan Zhaowei, Shen Hong, et al. Clinical Study of Weishu capsule ( ) in treating precancerous lesions of chronic atrophic gastritis) in treating precancerous lesions of chronic atrophic gastritis. [J]. Chinese Journal of Integrative Medicine 5(3):193-196(1999)
Weimin, L., Zhaowei, S., Hong, S. et al. Clinical Study of Weishu capsule () in treating precancerous lesions of chronic atrophic gastritis) in treating precancerous lesions of chronic atrophic gastritis., CJIM 5, 193–196 (1999). https://doi.org/10.1007/BF02935170DOI:
Lu Weimin, Shan Zhaowei, Shen Hong, et al. Clinical Study of Weishu capsule ( ) in treating precancerous lesions of chronic atrophic gastritis) in treating precancerous lesions of chronic atrophic gastritis. [J]. Chinese Journal of Integrative Medicine 5(3):193-196(1999) DOI: 10.1007/BF02935170.
Clinical Study of Weishu capsule ( ) in treating precancerous lesions of chronic atrophic gastritis) in treating precancerous lesions of chronic atrophic gastritis
摘要
Objective: To explore the therapeutic effect and mechanism of Weishu capsule (WSC)
in treating precancerous lesions of chronic atrophic gastritis (CAG).Methods: Seventy-five cases of precancerous lesions of CAG were distributed to two groups randomly
the WSC group (45 patients) treated with WSC taken orally and the Weining granule (WNG) group (30 patients) treated with Weining granule orally. The treatment course of both groups were 6 months. The clinical and pathological effects and the changes in scores of atrophy
intestinal metaplasia (IM) and its subgroups
dysplasia
carcinoembryonic antigen and proliferating cell nuclear antigen expression were observed before and after treatment.Results: The total effective rate was 91% and the effective rate of atrophy
IM
dysplasia in the WSC group were 64%
67% and 65% respectively
and the respective scores were lowered significantly after treatment. Compared with the WNG group
the difference between the two groups was statistically significant (P < 0.01
P < 0.05). Immunohistochemical test showed that WSC could inhibit the subgroups of IM
circinoembryonic antigen and proliferating cell nuclear antigen expression significantly (P < 0.01).Conclusions: WSC could significantly improve the clinical and pathological changes in the precancerous lesions of CAG. The mechanism might be related to the inducing and promoting effect of WSC on the differentiation and maturity of IM cells and dysplasia cells. WSC could also inhibit and correct the abnormal proliferation of cells.
Abstract
Objective: To explore the therapeutic effect and mechanism of Weishu capsule (WSC)
in treating precancerous lesions of chronic atrophic gastritis (CAG).Methods: Seventy-five cases of precancerous lesions of CAG were distributed to two groups randomly
the WSC group (45 patients) treated with WSC taken orally and the Weining granule (WNG) group (30 patients) treated with Weining granule orally. The treatment course of both groups were 6 months. The clinical and pathological effects and the changes in scores of atrophy
intestinal metaplasia (IM) and its subgroups
dysplasia
carcinoembryonic antigen and proliferating cell nuclear antigen expression were observed before and after treatment.Results: The total effective rate was 91% and the effective rate of atrophy
IM
dysplasia in the WSC group were 64%
67% and 65% respectively
and the respective scores were lowered significantly after treatment. Compared with the WNG group
the difference between the two groups was statistically significant (P < 0.01
P < 0.05). Immunohistochemical test showed that WSC could inhibit the subgroups of IM
circinoembryonic antigen and proliferating cell nuclear antigen expression significantly (P < 0.01).Conclusions: WSC could significantly improve the clinical and pathological changes in the precancerous lesions of CAG. The mechanism might be related to the inducing and promoting effect of WSC on the differentiation and maturity of IM cells and dysplasia cells. WSC could also inhibit and correct the abnormal proliferation of cells.
关键词
Weishu capsuleQi deficiency and blood stasisChronic Atrophic Gastritisprecancerous lesion
Keywords
Weishu capsuleQi deficiency and blood stasisChronic Atrophic Gastritisprecancerous lesion
references
10 1997: 1585.
1983; 5: 261–262.
1990; 5: 318–319.
1981:29.
1986;(1): 1.
1995;(11): 735.
PCNA, AgNOR 1995; 4: 19.
1995:118–121.
523 1992; 16(2): 33–36.
2 1993: 185.
Hall PA, Lerrison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 160 (4): 285.
Effect of mica monomer powder on chief and parietal cells as well as G and D cells in gastric mucosa of chronic atrophic gastritis in rats
Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid
Academic summary of the world integrated medicine congress
Randomized double-blind clinical trial of Moluodan (摩罗丹) for the treatment of chronic atrophic gastritis with dysplasia
Related Author
No data
Related Institution
Academy of Traditional Chinese Medicine of Jiangsu Province
Sir Run Run Shaw Clinical Medical Institute, Zheijiang University, Zheijiang
Nephropathy Department, The First Affiliated Hospital to Anhui College of TCM
Xiyuan Hospital, China Academy of Chinese Medical Sciences